Close

Ayala Pharmaceuticals Inc. (AYLA) Reports Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102

Go back to Ayala Pharmaceuticals Inc. (AYLA) Reports Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102
(NASDAQ: AYLA) Delayed: 1.00 +0.07 (7.53%)
Previous Close $0.93    52 Week High
Open $0.90    52 Week Low
Day High $1.01    P/E N/A 
Day Low $0.90    EPS
Volume 250,560